|
|
||||||||
The Journal of Immunology, Vol 156, Issue 2 727-734, Copyright © 1996 by American Association of Immunologists
ARTICLES |
S Deaglio, U Dianzani, AL Horenstein, JE Fernandez, C van Kooten, M Bragardo, A Funaro, G Garbarino, F Di Virgilio, J Banchereau and F Malavasi
Department of Genetics, Biology, and Medical Chemistry, University of Torino, Italy.
Human CD38, a pleiotropic molecule with ADP-ribosyl cyclase activity, regulates activation and growth of several cell types. Its in vivo function is incompletely determined, mainly due to the lack of evidence concerning the existence of a single or multiple ligands. We recently observed that CD38 rules a selectin-type adhesion between lymphoid cells and HUVECs. A panel of murine mAbs raised against HUVEC included one (Moon-1) constantly blocking the CD38-mediated adhesion of several cell lines to HUVEC. Tissue distribution studies and an extended immunohistochemical analysis on the majority of normal human tissues revealed that the Moon-1 molecule displays a unique pattern of expression, being present at high levels on resting and activated vascular endothelium, on the majority of monocytes, platelets, NK cells, and to a lesser extent on T, B, and myeloid cells. The Moon-1 structure of an apparent molecular mass of 120 kDa proved to be a ligand for human CD38, as inferred by the direct binding observed when using a chimeric mouse CD8 alpha-human CD38 (mCD8 alpha-hCD38) molecule as a probe in Western blot experiments. Furthermore, Ab-induced modulation experiments highlighted an association between the Moon-1 molecule and human CD38 on the surface of cell lines coexpressing the two structures, which also share a common regulation system of surface expression. Finally, direct ligation of Moon-1 on T cell lines caused a relevant increase in the cytoplasmic concentration of calcium ([Ca2+]i).
This article has been cited by other articles:
![]() |
F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology Physiol Rev, July 1, 2008; 88(3): 841 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hartiala, J. Hytonen, J. Pelkonen, K. Kimppa, A. West, M. A. Penttinen, J. Suhonen, R. Lahesmaa, and M. K. Viljanen Transcriptional response of human dendritic cells to Borrelia garinii--defective CD38 and CCR7 expression detected J. Leukoc. Biol., July 1, 2007; 82(1): 33 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, T. Vaisitti, R. Billington, L. Bergui, P. Omede', A. A. Genazzani, and F. Malavasi CD38/CD19: a lipid raft-dependent signaling complex in human B cells Blood, June 15, 2007; 109(12): 5390 - 5398. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ortolan, E. V. Tibaldi, B. Ferranti, L. Lavagno, G. Garbarino, R. Notaro, L. Luzzatto, F. Malavasi, and A. Funaro CD157 plays a pivotal role in neutrophil transendothelial migration Blood, December 15, 2006; 108(13): 4214 - 4222. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tinhofer, G. Rubenzer, C. Holler, E. Hofstaetter, M. Stoecher, A. Egle, M. Steurer, and R. Greil Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia Blood, November 1, 2006; 108(9): 2950 - 2956. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, T. Vaisitti, S. Aydin, E. Ferrero, and F. Malavasi In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia Blood, August 15, 2006; 108(4): 1135 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Frasca, G. Fedele, S. Deaglio, C. Capuano, R. Palazzo, T. Vaisitti, F. Malavasi, and C. M. Ausiello CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells Blood, March 15, 2006; 107(6): 2392 - 2399. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, T. Vaisitti, L. Bergui, L. Bonello, A. L. Horenstein, L. Tamagnone, L. Boumsell, and F. Malavasi CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival Blood, April 15, 2005; 105(8): 3042 - 3050. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Munoz, M.-d.-C. Navarro, E. J. Pavon, J. Salmeron, F. Malavasi, J. Sancho, and M. Zubiaur CD38 Signaling in T Cells Is Initiated within a Subset of Membrane Rafts Containing Lck and the CD3-{zeta} Subunit of the T Cell Antigen Receptor J. Biol. Chem., December 12, 2003; 278(50): 50791 - 50802. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Righi, S. Deaglio, C. Pecchioni, A. Gregorini, A. L. Horenstein, G. Bussolati, A. Sapino, and F. Malavasi Role of CD31/Platelet Endothelial Cell Adhesion Molecule-1 Expression in in Vitro and in Vivo Growth and Differentiation of Human Breast Cancer Cells Am. J. Pathol., April 1, 2003; 162(4): 1163 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. O'Brien, P. Lim, J. Sun, and S. M. Albelda PECAM-1-dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization Blood, April 1, 2003; 101(7): 2816 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Marchetti, A. Antonelli, R. Lupi, L. Marselli, P. Fallahi, C. Nesti, G. Baj, and E. Ferrannini Prolonged In Vitro Exposure to Autoantibodies Against CD38 Impairs the Function and Survival of Human Pancreatic Islets Diabetes, December 1, 2002; 51(90003): S474 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, A. Capobianco, A. Cali, F. Bellora, F. Alberti, L. Righi, A. Sapino, C. Camaschella, and F. Malavasi Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum Blood, November 15, 2002; 100(10): 3782 - 3789. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, M. Zubiaur, A. Gregorini, F. Bottarel, C. M. Ausiello, U. Dianzani, J. Sancho, and F. Malavasi Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells Blood, April 1, 2002; 99(7): 2490 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ibrahim, M. Keating, K.-A. Do, S. O'Brien, Y. O. Huh, I. Jilani, S. Lerner, H. M. Kantarjian, and M. Albitar CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia Blood, July 1, 2001; 98(1): 181 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, G. Baj, P. Marchetti, P. Fallahi, N. Surico, C. Pupilli, F. Malavasi, and E. Ferrannini Human Anti-CD38 Autoantibodies Raise Intracellular Calcium and Stimulate Insulin Release in Human Pancreatic Islets Diabetes, May 1, 2001; 50(5): 985 - 991. [Abstract] [Full Text] |
||||
![]() |
T. Musso, S. Deaglio, L. Franco, L. Calosso, R. Badolato, G. Garbarino, U. Dianzani, and F. Malavasi CD38 expression and functional activities are up-regulated by IFN-{gamma} on human monocytes and monocytic cell lines J. Leukoc. Biol., April 1, 2001; 69(4): 605 - 612. [Abstract] [Full Text] |
||||
![]() |
R. Mallone, A. Funaro, M. Zubiaur, G. Baj, C. M. Ausiello, C. Tacchetti, J. Sancho, C. Grossi, and F. Malavasi Signaling through CD38 induces NK cell activation Int. Immunol., April 1, 2001; 13(4): 397 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Konopleva, Z. Estrov, S. Zhao, M. Andreeff, and K. Mehta Ligation of Cell Surface CD38 Protein with Agonistic Monoclonal Antibody Induces a Cell Growth Signal in Myeloid Leukemia Cells J. Immunol., November 1, 1998; 161(9): 4702 - 4708. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Cao, M. Huber, N. Beauchemin, J. Famiglietti, S. M. Albelda, and A. Veillette Regulation of Mouse PECAM-1 Tyrosine Phosphorylation by the Src and Csk Families of Protein-tyrosine Kinases J. Biol. Chem., June 19, 1998; 273(25): 15765 - 15772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morra, M. Zubiaur, C. Terhorst, J. Sancho, and F. Malavasi CD38 is functionally dependent on the TCR/CD3 complex in human T cells FASEB J, May 1, 1998; 12(7): 581 - 592. [Abstract] [Full Text] |
||||
![]() |
A. Cesano, S. Visonneau, S. Deaglio, F. Malavasi, and D. Santoli Role of CD38 and Its Ligand in the Regulation of MHC-Nonrestricted Cytotoxic T Cells J. Immunol., February 1, 1998; 160(3): 1106 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, M. Morra, R. Mallone, C. M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger, and F. Malavasi Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member J. Immunol., January 1, 1998; 160(1): 395 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Khoo, M.-K. Han, J. B. Park, S. W. Chae, U.-H. Kim, H. C. Lee, B. H. Bay, and C. F. Chang Localization of the Cyclic ADP-ribose-dependent Calcium Signaling Pathway in Hepatocyte Nucleus J. Biol. Chem., August 4, 2000; 275(32): 24807 - 24817. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Zilber, S. Gregory, R. Mallone, S. Deaglio, F. Malavasi, D. Charron, and C. Gelin CD38 expressed on human monocytes: A coaccessory molecule in the superantigen-induced proliferation PNAS, March 14, 2000; 97(6): 2840 - 2845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |